Year 2022 / Volume 114 / Number 4
Original
Gynecological history to diagnosis and pregnancy outcomes in diagnosed Wilson's disease patients under therapy – A bicentric matched-control cohort study

198-203

DOI: 10.17235/reed.2020.7444/2020

Joana Roseira, Rita Lopes, Mário Jorge Silva, Ana Margarida Vieira, Margarida Sampaio, Filipe Calinas,

Abstract
Introduction: most studies narrowly focus on pregnancy outcome comparisons between Wilson’s disease (WD) patients on and off treatment. We aimed to identify menses irregularities in untreated WD, and to evaluate pregnancy outcomes in treated WD patients as compared to matched controls (with and without liver disease). Methods: females with WD, hepatitis C (liver disease controls), and other gastrointestinal conditions (controls without liver disease) were identified at two tertiary hospital gastroenterology departments. Gynecological and obstetric data were retrospectively collected. A comparison of gynecological and obstetric outcomes was performed between the groups, and regression models were used to further assess obstetric outcomes. Results: a total of 18 females with WD were identified, comprising 19 pregnancies under treatment in 11 patients, and 20 females were included in each control group. Age and liver disease stage were adjusted between groups. The incidence of menses irregularities was higher for WD (late menarche, 83 % vs. 10 % vs. 10 %, p < 0.01; irregular cycles, 100 % vs. 20 % vs. 20 %, p < 0.01; amenorrhea, 67 % vs. 10 % vs. 5 %, p < 0.01). Logistic regression models identified WD as a predictor of miscarriage and low birth weight (OR: 6.0; CI: 1.1-33.3; p < 0.05) but not of birth defects. Neither therapies (D-penicillamine 300 mg or zinc acetate 150 mg) nor disease presentation (hepatic and/or neurological) were associated with obstetric complications in WD subjects. Conclusion: there was a higher incidence of menses irregularities in untreated females with WD. In addition, our data suggest that treated WD still carries a higher risk of spontaneous abortion and low birth weight when compared to matched control groups with and without liver disease.
Share Button
New comment
Comments
No comments for this article
References
1. Ferenci P, Czlonkowska A, Stremmel W, et al. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol 2012;56:671-85.
2. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: An update. Hepatology 2008;47:2089-111.
3. Liu J, Luan J, Zhou X, et al. Epidemiology, diagnosis, and treatment of Wilson’s disease. Intractable Rare Dis Res 2017;6:249-55.
4. Pfeiffenberger J, Beinhardt S, Gotthardt DN, et al. Pregnancy in Wilson’s disease: Management and outcome. Hepatology 2018;67:1261-9.
5. Oga M, Matsui N, Anai T, et al. Copper disposition of the fetus and placenta in a patient with untreated Wilson’s disease. Am J Obstet Gynecol 1993;169:196-8.
6. Kaushansky A, Frydman M, Kaufman H, et al. Endocrine studies of the ovulatory disturbances in Wilson’s disease (hepatolenticular degeneration). Fertil Steril 1987;47:270-3.
7. Saroli Palumbo C, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med 2019;7:S65.
8. Brewer GJ. The Modern Treatment of Wilson Disease. J Gastrointest Dig Syst 2015;5:312. DOI: 10.4172/2161-069x.1000312
9. Walshe JM. The management of pregnancy in Wilson’s disease treated with trientine. Q J Med 1986;58:81-7.
10. Brewer GJ, Johnson VD, Dick RD, et al. Treatment of Wilson’s disease with zinc. XVII: treatment during pregnancy. Hepatology 2000;31:364-70.
11. Ferenci P. Chapter 24 - Wilson Disease. In: Bacon BR, O’Grady JG, Bisceglie AM (eds). Comprehensive Clinical Hepatology (Second Edition). Edinburgh: Mosby; 2005. p. 351-67.
12. Mjolnerod OK, Dommerud SA, Rasmussen K, et al. Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy. Lancet (London, England) 1971;1:673-5.
13. Keen CL, Cohen NL, Lonnerdal B, et al. Teratogenesis and low copper status resulting from triethylenetetramine in rats. Proc Soc Exp Biol Med 1983;173:598-605.
14. Keen CL, Uriu-Hare JY, Hawk SN, et al. Effect of copper deficiency on prenatal development and pregnancy outcome. Am J Clin Nutr 1998;67:1003S-11S.
15. Hagstrom H, Hoijer J, Marschall H-U, et al. Outcomes of Pregnancy in Mothers With Cirrhosis: A National Population-Based Cohort Study of 1.3 Million Pregnancies. Hepatol Commun 2018;2:1299-305.
16. Rabiee A, Hamilton JPA. Pregnancy in Wilson disease. Hepatology 2018;67:1201-3.
17. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003;23:139-42.
18. Castéra L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50.
19. Karlas T, Hempel M, Tröltzsch M, et al. Non-invasive evaluation of hepatic manifestation in Wilson disease with transient elastography, ARFI, and different fibrosis scores. Scand J Gastroenterol 2012;47:1353-61.
20. Reindollar RH, Byrd JR, McDonough PG. Delayed sexual development: a study of 252 patients. Am J Obstet Gynecol 1981;140:371-80.
21. Filicori M, Butler JP, Crowley WFJ. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest 1984;73:1638-47.
22. Regan L, Rai R. Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:839-54.
23. Perinatal care at the threshold of viability. American Academy of Pediatrics Committee on Fetus and Newborn. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Pediatrics 1995;96:974-6.
24. Marden PM, Smith DW, McDonal MJ. Congenital anomalies in the newborn infant, including minor variations. A study of 4,412 babies by surface examination for anomalies and buccal smear for sex chromatin. J Pediatr 1964;64:357-71.
25. Sinha S, Taly AB, Prashanth LK, et al. Successful pregnancies and abortions in symptomatic and asymptomatic Wilson’s disease. J Neurol Sci 2004;217:37-40.
26. Wang H, Chow S-C. Sample Size Calculation for Comparing Proportions. In: D'Agostino RB, Sullivan L, Massaro J (eds.). Wiley Encyclopedia of Clinical Trials. Wiley; 2007. DOI: 10.1002/9780471462422.eoct005
27. Palsson OS, Whitehead WE, van Tilburg MAL, et al. Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians. Gastroenterology 2016;S0016-5085(16)00180-3. DOI: 10.1053/j.gastro.2016.02.014
28. Krysiak R, Handzlik-Orlik G, Okopien B. Endocrine symptoms as the initial manifestation of Wilson’s disease. Yale J Biol Med 2012;85:249-54.
29. Erkan T, Aktuglu C, Gulcan EM, et al. Wilson disease manifested primarily as amenorrhea and accompanying thrombocytopenia. J Adolesc Health 2002;31:378-80.
30. Yu X-E, Pan M, Han Y-Z, et al. The study of Wilson disease in pregnancy management. BMC Pregnancy Childbirth 2019;19:522.
31. Sini M, Sorbello O, Civolani A, et al. Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson’s Disease. Dig liver Dis 2012;44(6):487-91.
32. Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep 2008;57:1-5.
Related articles
Citation tools
Roseira J, Lopes R, Silva M, Vieira A, Sampaio M, Calinas F, et all. Gynecological history to diagnosis and pregnancy outcomes in diagnosed Wilson's disease patients under therapy – A bicentric matched-control cohort study . 7444/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1612 visits.
This article has been downloaded 165 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 27/07/2020

Accepted: 04/12/2020

Online First: 04/01/2021

Published: 07/04/2022

Article revision time: 121 days

Article Online First time: 161 days

Article editing time: 619 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2024 y Creative Commons. The Spanish Journal of Gastroenterology